{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:35:41Z","timestamp":1792193741342,"version":"4.4.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Fibrillary glomerulonephritis (FGN) is a rare glomerular disease featured by the randomly arranged 12- to 24-nm fibrils under electron microscopy (EM). Up to 10% of FGN patients have monoclonal gammopathy. However, distinguishing between FGN as monoclonal gammopathy of renal significance (MGRS) and FGN from other causes with incidental monoclonal gammopathy of undetermined significance (MGUS) can be challenging, as the current way of demonstrating monoclonality is flawed due to (1) the suboptimal sensitivity of kappa staining by immunofluorescence in frozen tissue (IF-F) as compared to pronase-digested paraffin sections (IF-P), causing incorrect labeling of light chain restriction; (2) the unavailability of immunoglobulin G (IgG) subtyping in some centers; and (3) the unavailability of tests demonstrating the monoclonality of highly variable VH or VL domains in immunoglobulin structures in clinical use. The discovery of DnaJ homolog subfamily B member 9 (DNAJB9) allows diagnosis for FGN with less reliance on EM, and the summary of recent studies revealed that genuine MGRS is extremely rare among FGN. Further research integrating IF-P, IgG subtyping, VH or VL domain monoclonality confirmation, and DNAJB9 as diagnostic modalities, with corresponding clinical data including treatment response and prognosis, is required for a better understanding of this subject.<\/jats:p>","DOI":"10.3389\/fonc.2022.880923","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:53:22Z","timestamp":1653458002000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges"],"prefix":"10.3389","volume":"12","author":[{"given":"Yi","family":"Da","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giap Hean","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Joo","family":"Chng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinnie Yentia","family":"Soekojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000180846","article-title":"Nephrotic Syndrome Associated With Amyloid-Like Glomerular Deposits","volume":"18","author":"Rosenmann","year":"1977","journal-title":"Nephron"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary Glomerulonephritis","volume":"14","author":"Andeen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-Term Kidney Disease Outcomes in Fibrillary Glomerulonephritis: A Case Series of 27 Patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.10.022","article-title":"Familial Fibrillary Glomerulonephritis in Living Related Kidney Transplantation","volume":"6","author":"Jeyabalan","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12447","article-title":"Fibrillary Glomerulonephritis: An Apparent Familial Form","volume":"20","author":"Ying","year":"2015","journal-title":"Nephrology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New Developments in the Diagnosis of Fibrillary Glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000440815","article-title":"End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive Anzdata Registry Cases","volume":"42","author":"Mallett","year":"2015","journal-title":"Am J Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary Glomerulonephritis: An Update","volume":"4","author":"Rosenstock","year":"2019","journal-title":"Kidney Int Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The Evaluation of Monoclonal Gammopathy of Renal Significance: A Consensus Report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020010054","article-title":"Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (Mgrs) Lesions on Kidney Biopsy in Patients With Monoclonal Gammopathy","volume":"31","author":"Klomjit","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0337","article-title":"Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic Review","volume":"85","author":"Wadhera","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-005-0361-z","article-title":"Fibrillary Glomerulonephritis Associated With Monoclonal Gammopathy of Undetermined Significance Showing Lambda-Type Bence Jones Protein","volume":"9","author":"Nagao","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-015-0198-y","article-title":"Simultaneous Occurrence of Fibrillary Glomerulonephritis and Renal Lesions in Nonmalignant Monoclonal IgM Gammopathy","volume":"17","author":"Wu","year":"2016","journal-title":"BMC Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.01.028","article-title":"Proliferative Glomerulonephritis With Monoclonal Immunoglobulin G Deposits Is Associated With High Rate of Early Recurrence in the Allograft","volume":"94","author":"Said","year":"2018","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-Term Outcome of Renal Transplantation in light chain Deposition Disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.04.015","article-title":"Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (Mgrs)-Associated Lesions: A Case Series","volume":"79","author":"Heybeli","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1810907","article-title":"Monoclonal Gammopathy of Renal Significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.01.001","article-title":"Diagnostic Approach to Glomerulonephritis With Fibrillar Igg Deposits and Light Chain Restriction","volume":"6","author":"Kudose","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.04.026","article-title":"A Fresh Perspective on Monoclonal Gammopathies of Renal Significance","volume":"6","author":"Aucouturier","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001990","article-title":"Immunofluorescence on Pronase-Digested Paraffin Sections: A Valuable Salvage Technique for Renal Biopsies","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"Dnajb9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017050566","article-title":"Dnaj Homolog Subfamily B Member 9 Is a Putative Autoantigen in Fibrillary Gn","volume":"29","author":"Andeen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017030306","article-title":"Dnaj Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary Gn","volume":"29","author":"Dasari","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.12.004","article-title":"Dnajb9 Is Not Transcriptionally Upregulated in the Glomerulus in Fibrillary Glomerulonephritis","volume":"5","author":"Avasare","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0002532020","article-title":"Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (Dnajb9)","volume":"1","author":"Klomjit","year":"2020","journal-title":"Kidney360"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.03.017","article-title":"Congophilic Fibrillary Glomerulonephritis: A Case Series","volume":"72","author":"Alexander","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.04.015","article-title":"Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases","volume":"77","author":"Said","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.01.024","article-title":"Serum Levels of DNAJB9 Are Elevated in Fibrillary Glomerulonephritis Patients","volume":"95","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.01.034","article-title":"Elevated Serum Concentrations of DNAJB9 in Fibrillary Glomerulonephritis: Another Step Toward Understanding a Progressive Disease","volume":"95","author":"Andeen","year":"2019","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa065","article-title":"Treatment of Fibrillary Glomerulonephritis With Rituximab: A 12-Month Pilot Study","volume":"36","author":"Erickson","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.66","article-title":"Fibrillary Glomerulonephritis: An Entity With Unusual Immunofluorescence Features","volume":"31","author":"Alpers","year":"1987","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.kint.2020.02.025","article-title":"DNAJB9-Positive Monotypic Fibrillary Glomerulonephritis Is Not Associated With Monoclonal Gammopathy in the Vast Majority of Patients","volume":"98","author":"Said","year":"2020","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.01.018","article-title":"Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series","volume":"76","author":"El Ters","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007072","article-title":"An Animal Model of MGRS: What Advances Await","volume":"136","author":"Leung","year":"2020","journal-title":"Blood"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.880923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:53:25Z","timestamp":1653458005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.880923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":34,"alternative-id":["10.3389\/fonc.2022.880923"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.880923","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"880923"}}